Poet Technologies Q3 2026: Revenue Nearly Quadruples as Optical Engines Ship
As seen on the 24/7 Wall St. homepage on November 16, 2026.
Revenue nearly quadrupled from a year ago as the optical engine business finally starts shipping, and the Lumilens supply deal has already parked $30.1 million of deferred customer consideration waiting to be recognized. With $774.4 million in cash and investments, funding risk is off the table ahead of 800G and 1.6T production targeted for Q2 2027.
Continue ReadingShow less
Poet Technologies reported Q3 2026 revenue of $1.03 million, up 243.8% from $298,434 in the same quarter a year earlier, beating the consensus estimate by 5.9%. The loss per share came in at negative $0.04, a 20% beat against the negative $0.05 estimate, though that figure was shaped by a $6.38 million non-cash gain on derivative warrant liabilities and $5.06 million of other income including interest.
The commercial engine behind the revenue surge is the Lumilens supply agreement, which carries an initial $50 million purchase order and potential cumulative value exceeding $500 million over five years. As of the end of September, that deal had already generated $30.14 million in deferred customer consideration sitting on the balance sheet, waiting to be recognized as product revenue when deliveries are made.
The balance sheet itself is a meaningful part of the story. Poet ended the quarter with $774.4 million in cash and investments, a position built through a $400 million registered direct offering closed in May 2026 and an earlier $150 million raise in January. Management stated that existing resources are sufficient to fund operations well beyond the next twelve months, effectively removing near-term dilution or funding risk as the primary investor concern.
Sponsored
The next concrete milestones to track are prototype completions for 800G and 1.6T transmitters targeted for Q4 2026, with production of those transceivers set for Q2 2027. Module prototypes follow in Q1 2027, with production in Q3 2027. Management's 2026 milestone plan budgets roughly $44 million for R&D, Malaysia manufacturing expansion, and corporate development, of which about $16.7 million had been spent through September 30.
The EPS history shows a choppier road than this quarter suggests. Poet posted losses of negative $0.32 in Q1 2026 and negative $0.25 in Q4 2025, both of which significantly missed estimates, before Q2 2026 and Q3 2026 returned to beating expectations. The quarter-to-quarter volatility reflects how heavily the bottom line is influenced by non-cash items, including warrant fair value swings and stock-based compensation of $5.72 million in Q3 alone, so the loss narrowing is real but needs that context.
Mentioned: POET